FITC Anti-Human TCR γ/δ Antibody[B1]

FITC Anti-Human TCR γ/δ Antibody[B1]

Introducing the FITC Anti-Human TCR γ/δ Antibody [B1], a highly specialized and meticulously developed product designed to facilitate accurate and efficient detection of the T-cell receptor gamma/delta (TCR γ/δ) in human samples. This antibody, conjugated with fluorescein isothiocyanate (FITC), offers exceptional sensitivity and specificity, making it an invaluable tool for researchers and clinicians alike.

The FITC Anti-Human TCR γ/δ Antibody [B1] has been meticulously engineered using cutting-edge technology and rigorous quality control measures to ensure optimal performance and reproducibility. Its exceptional affinity for the TCR γ/δ epitope enables precise identification and quantification of TCR γ/δ-expressing cells, enabling comprehensive analysis of immune responses and disease progression.

This antibody's conjugation with FITC, a widely utilized fluorochrome, empowers researchers with the ability to visualize and analyze TCR γ/δ expression through flow cytometry, immunofluorescence, and other fluorescence-based techniques. The FITC label, known for its high fluorescence intensity and photostability, guarantees reliable and accurate results, even in demanding experimental conditions.

The FITC Anti-Human TCR γ/δ Antibody [B1] exhibits exceptional specificity, ensuring minimal cross-reactivity with other T-cell receptor subtypes or non-specific antigens. This specificity, combined with its high sensitivity, enables precise discrimination and enumeration of TCR γ/δ-positive cells, facilitating comprehensive investigations into immune responses, disease pathogenesis, and therapeutic interventions.

Furthermore, this antibody's compatibility with a wide range of sample types, including peripheral blood, lymphoid tissues, and cell cultures, enhances its versatility and applicability across various research domains. Its robust performance and consistent results make it an indispensable tool for immunologists, oncologists, and researchers studying T-cell biology and related fields.

In summary, the FITC Anti-Human TCR γ/δ Antibody [B1] represents a pinnacle of scientific innovation, offering researchers and clinicians an exceptional tool for the accurate and reliable detection of TCR γ/δ-expressing cells. With its unparalleled sensitivity, specificity, and compatibility, this antibody empowers users to unravel the complexities of immune responses and disease mechanisms, paving the way for advancements in diagnostics, therapeutics, and personalized medicine.